| Megan Kay Suh, MSN, APRN, FNP-C | |
|
611 W Francis St Ste 200, North Platte, NE 69101-0614 | |
| (308) 568-3500 | |
| Not Available |
| Full Name | Megan Kay Suh |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 611 W Francis St Ste 200, North Platte, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235616368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 112567 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great Plains Health | North platte, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Platte Nebraska Hospital Corporation | 6507856697 | 181 |
News Archive
Research revealing early changes at epigenetic level points to possible new prevention strategies for ovarian cancer. The discovery of early changes in the cells of the Fallopian tubes of women carrying the BRCA genetic mutation could open the way for new preventative strategies for ovarian cancer, reducing the need for invasive surgery, according to research published today in science journal Nature Communications.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Population Health Analytics solution, which delivers enterprise business intelligence to support population health management, risk stratification, pay-for-performance quality measures, capitation, and shared savings adjudication for accountable care organizations and other new payer-provider risk models.
Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City.
A study by researchers from Loma Linda University School of Public Health and the Czech Republic has found that timing and frequency of meals play a role in predicting weight loss or gain.
A special insurance program for about 30,000 people with a history of cancer, heart disease and other serious illnesses will be extended for an additional two months so enrollees can continue treatments while they search for other coverage, the Obama administration announced Tuesday.
› Verified 5 days ago
| Entity Name | North Platte Nebraska Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700855533 PECOS PAC ID: 6507856697 Enrollment ID: O20040512000889 |
News Archive
Research revealing early changes at epigenetic level points to possible new prevention strategies for ovarian cancer. The discovery of early changes in the cells of the Fallopian tubes of women carrying the BRCA genetic mutation could open the way for new preventative strategies for ovarian cancer, reducing the need for invasive surgery, according to research published today in science journal Nature Communications.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Population Health Analytics solution, which delivers enterprise business intelligence to support population health management, risk stratification, pay-for-performance quality measures, capitation, and shared savings adjudication for accountable care organizations and other new payer-provider risk models.
Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City.
A study by researchers from Loma Linda University School of Public Health and the Czech Republic has found that timing and frequency of meals play a role in predicting weight loss or gain.
A special insurance program for about 30,000 people with a history of cancer, heart disease and other serious illnesses will be extended for an additional two months so enrollees can continue treatments while they search for other coverage, the Obama administration announced Tuesday.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan Kay Suh, MSN, APRN, FNP-C 1802 N Sheridan Ave Apt 3, North Platte, NE 69101-2108 Ph: (308) 672-2268 | Megan Kay Suh, MSN, APRN, FNP-C 611 W Francis St Ste 200, North Platte, NE 69101-0614 Ph: (308) 568-3500 |
News Archive
Research revealing early changes at epigenetic level points to possible new prevention strategies for ovarian cancer. The discovery of early changes in the cells of the Fallopian tubes of women carrying the BRCA genetic mutation could open the way for new preventative strategies for ovarian cancer, reducing the need for invasive surgery, according to research published today in science journal Nature Communications.
Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Population Health Analytics solution, which delivers enterprise business intelligence to support population health management, risk stratification, pay-for-performance quality measures, capitation, and shared savings adjudication for accountable care organizations and other new payer-provider risk models.
Actinium Pharmaceuticals, Inc. a biotechnology company focused on developing innovative, alpha particle radiotherapy targeted cancer treatments addressing major unmet medical needs, today announced that it has successfully treated the first cohort of patients in a Phase I/II study of Actimab-A in Acute Myeloid Leukemia (AML) clinical trial. Patients were treated at Memorial Sloan Kettering Cancer Center in New York City.
A study by researchers from Loma Linda University School of Public Health and the Czech Republic has found that timing and frequency of meals play a role in predicting weight loss or gain.
A special insurance program for about 30,000 people with a history of cancer, heart disease and other serious illnesses will be extended for an additional two months so enrollees can continue treatments while they search for other coverage, the Obama administration announced Tuesday.
› Verified 5 days ago
Kimberly Ann Behnk, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 W Leota St, North Platte, NE 69101 Phone: 308-568-3546 | |
Dr. Theresa Causa, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Great Plains Health, 601 W Leota St, North Platte, NE 69101 Phone: 308-568-8000 | |
Mrs. Stacy Leigh Haman, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 210 Mcneel Ln, North Platte, NE 69101 Phone: 308-221-6262 | |
Kourtney Sabala, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 321 E 3rd St, North Platte, NE 69101 Phone: 308-221-4651 Fax: 308-217-1643 | |
Jenifer Elaine Fowler, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 118 E C St, North Platte, NE 69101 Phone: 308-221-6068 Fax: 308-221-6071 | |
Adam David Diediker, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 215 Mcneel Ln, North Platte, NE 69101 Phone: 308-568-3800 | |
Analisa Colglazier, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 601 W Leota St, North Platte, NE 69101 Phone: 308-696-8000 |